A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
Titel:
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
Auteur:
Yoon, Sae-Bom Hong, Hyowon Lim, Hee-Jong Choi, Ji Hye Choi, Yoon Pyo Seo, Seong Wook Lee, Hyuk Woo Chae, Chong Hak Park, Woo-Kyu Kim, Hyun Young Jeong, Daeyoung De, Tran Quang Myung, Chang-Seon Cho, Heeyeong
Verschenen in:
Acta pharmaceutica sinica B
Paginering:
Jaargang 13 () nr. 3 pagina's 1093-1109
Jaar:
2023
Inhoud:
Uitgever:
Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences